Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Artificial Intelligenc e is the subject of a report. According to news reporting out of Cleveland, Ohio , by NewsRx editors, research stated, "The high failure rate of clinical trials in Alzheimer's disease (AD) and AD-related dementia (ADRD) is due to a lack of u nderstanding of the pathophysiology of disease, and this deficit may be addresse d by applying artificial intelligence (AI) to ‘big data' to rapidly and effectiv ely expand therapeutic development efforts. Recent accelerations in computing po wer and availability of big data, including electronic health records and multi- omics profiles, have converged to provide opportunities for scientific discovery and treatment development." Our news journalists obtained a quote from the research from Cleveland Clinic, " Here, we review the potential utility of applying AI approaches to big data for discovery of disease-modifying medicines for AD/ADRD. We illustrate how AI tools can be applied to the AD/ADRD drug development pipeline through collaborative e fforts among neurologists, gerontologists, geneticists, pharmacologists, medicin al chemists, and computational scientists." According to the news editors, the research concluded: "AI and open data science expedite drug discovery and development of disease-modifying therapeutics for A D/ADRD and other neurodegenerative diseases."
NETL
NSTL